Original Article
Clinical Characteristics and Disease Course in Patients Treated With Efalizumab Following Suspension of Marketing Authorization by the European Medicines Agency: A Multicenter Observational Study
Perfil clínico y curso evolutivo de los pacientes tratados con efalizumab tras la suspensión de su autorización por la EMEA. Estudio observacional y multicéntrico
L. Morella,
, J.M. Carrascosaa, C. Ferrándiza, M. García-Bustinduyb, E. Fonsecac, G. Carreterod, E. Daudéne, S.E. Marrónf, J.L. López-Estebaranzg, M. Ferránh, M. Sánchez-Regañai, C. Muñoz-Santosj, I. Belinchónk, Luis Puigl, on behalf of the Spanish Psoriasis Group
Autor para correspondencia
a Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
b Servicio de Dermatología, Hospital Universitario de Canarias, Islas Canarias, Spain
c Servicio de Dermatología, Hospital Juan Canalejo, La Coruña, Spain
d Servicio de Dermatología, Hospital Universitario de Canarias Dr. Negrín, Islas Canarias, Spain
e Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, Spain
f Servicio de Dermatología, Hospital de Calatayud, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
g Servicio de Dermatología, Hospital de Alcorcón, Madrid, Spain
h Servicio de Dermatología, Hospital del Mar, Barcelona, Spain
i Servicio de Dermatología, Hospital del Sagrat Cor, Barcelona, Spain
j Servicio de Dermatología, Hospital Clínic i Provincial, Barcelona, Spain
k Servicio de Dermatología, Hospital General de Alicante, Alicante, Spain
l Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Ver másLeído
6280
Vecesse ha leído el artículo
2654
Total PDF
3626
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 16 | 9 | 25 |
| 2025 5 | 86 | 50 | 136 |
| 2025 4 | 104 | 22 | 126 |
| 2025 3 | 87 | 24 | 111 |
| 2025 2 | 119 | 28 | 147 |
| 2025 1 | 69 | 26 | 95 |
| 2024 12 | 54 | 24 | 78 |
| 2024 11 | 64 | 46 | 110 |
| 2024 10 | 53 | 44 | 97 |
| 2024 9 | 53 | 31 | 84 |
| 2024 8 | 71 | 49 | 120 |
| 2024 7 | 57 | 34 | 91 |
| 2024 6 | 47 | 25 | 72 |
| 2024 5 | 53 | 28 | 81 |
| 2024 4 | 63 | 31 | 94 |
| 2024 3 | 56 | 34 | 90 |
| 2024 2 | 46 | 34 | 80 |
| 2024 1 | 34 | 39 | 73 |
| 2023 12 | 46 | 33 | 79 |
| 2023 11 | 48 | 42 | 90 |
| 2023 10 | 42 | 28 | 70 |
| 2023 9 | 49 | 29 | 78 |
| 2023 8 | 37 | 27 | 64 |
| 2023 7 | 50 | 66 | 116 |
| 2023 6 | 58 | 28 | 86 |
| 2023 5 | 35 | 28 | 63 |
| 2023 4 | 24 | 18 | 42 |
| 2023 3 | 27 | 24 | 51 |
| 2023 2 | 18 | 15 | 33 |
| 2022 1 | 23 | 26 | 49 |
| 2022 12 | 30 | 40 | 70 |
| 2022 11 | 16 | 30 | 46 |
| 2022 10 | 15 | 26 | 41 |
| 2022 9 | 16 | 43 | 59 |
| 2022 8 | 17 | 30 | 47 |
| 2022 7 | 21 | 30 | 51 |
| 2022 6 | 23 | 29 | 52 |
| 2022 5 | 23 | 42 | 65 |
| 2022 4 | 29 | 45 | 74 |
| 2022 3 | 27 | 47 | 74 |
| 2022 2 | 14 | 32 | 46 |
| 2021 1 | 18 | 48 | 66 |
| 2021 12 | 26 | 48 | 74 |
| 2021 11 | 20 | 52 | 72 |
| 2021 10 | 25 | 67 | 92 |
| 2021 9 | 30 | 52 | 82 |
| 2021 8 | 14 | 37 | 51 |
| 2021 7 | 15 | 34 | 49 |
| 2021 6 | 10 | 33 | 43 |
| 2021 5 | 11 | 22 | 33 |
| 2021 4 | 18 | 58 | 76 |
| 2021 3 | 29 | 29 | 58 |
| 2021 2 | 39 | 29 | 68 |
| 2020 1 | 20 | 14 | 34 |
| 2020 12 | 25 | 12 | 37 |
| 2020 11 | 12 | 17 | 29 |
| 2020 10 | 26 | 11 | 37 |
| 2020 9 | 32 | 11 | 43 |
| 2020 8 | 26 | 24 | 50 |
| 2020 7 | 8 | 13 | 21 |
| 2020 6 | 12 | 23 | 35 |
| 2020 5 | 35 | 18 | 53 |
| 2020 4 | 14 | 16 | 30 |
| 2020 3 | 29 | 26 | 55 |
| 2020 2 | 5 | 3 | 8 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 0 | 8 | 8 |
| 2019 11 | 0 | 1 | 1 |
| 2019 9 | 0 | 3 | 3 |
| 2019 7 | 0 | 2 | 2 |
| 2019 6 | 0 | 7 | 7 |
| 2019 5 | 0 | 44 | 44 |
| 2019 4 | 0 | 1 | 1 |
| 2019 3 | 0 | 9 | 9 |
| 2018 7 | 0 | 1 | 1 |
| 2018 6 | 0 | 3 | 3 |
| 2018 5 | 0 | 4 | 4 |
| 2018 4 | 0 | 2 | 2 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 17 | 4 | 21 |
| 2018 1 | 24 | 10 | 34 |
| 2017 12 | 17 | 8 | 25 |
| 2017 11 | 18 | 2 | 20 |
| 2017 10 | 12 | 6 | 18 |
| 2017 9 | 9 | 10 | 19 |
| 2017 8 | 16 | 9 | 25 |
| 2017 7 | 12 | 3 | 15 |
| 2017 6 | 16 | 12 | 28 |
| 2017 5 | 15 | 6 | 21 |
| 2017 4 | 12 | 18 | 30 |
| 2017 3 | 14 | 18 | 32 |
| 2017 2 | 21 | 7 | 28 |
| 2016 1 | 9 | 9 | 18 |
| 2016 12 | 22 | 9 | 31 |
| 2016 11 | 24 | 7 | 31 |
| 2016 10 | 22 | 7 | 29 |
| 2016 9 | 22 | 9 | 31 |
| 2016 8 | 41 | 10 | 51 |
| 2016 7 | 37 | 10 | 47 |
| 2016 6 | 15 | 0 | 15 |
| 2016 5 | 4 | 14 | 18 |
| 2016 4 | 3 | 0 | 3 |
| 2016 3 | 4 | 0 | 4 |
| 2016 2 | 12 | 4 | 16 |
| 2015 1 | 4 | 1 | 5 |
| 2015 12 | 11 | 1 | 12 |
| 2015 11 | 7 | 1 | 8 |
| 2015 10 | 12 | 3 | 15 |
| 2015 9 | 5 | 2 | 7 |
| 2015 8 | 19 | 6 | 25 |
| 2015 7 | 24 | 7 | 31 |
| 2015 6 | 20 | 2 | 22 |
| 2015 5 | 53 | 7 | 60 |
| 2015 4 | 39 | 7 | 46 |
| 2015 3 | 34 | 7 | 41 |
| 2015 2 | 20 | 2 | 22 |
| 2015 1 | 19 | 7 | 26 |
| 2014 12 | 26 | 4 | 30 |
| 2014 11 | 29 | 8 | 37 |
| 2014 10 | 30 | 14 | 44 |
| 2014 9 | 28 | 6 | 34 |
| 2014 8 | 23 | 17 | 40 |
| 2014 7 | 27 | 18 | 45 |
| 2014 6 | 40 | 9 | 49 |
| 2014 5 | 50 | 9 | 59 |
| 2014 4 | 33 | 11 | 44 |
| 2014 3 | 38 | 10 | 48 |
| 2014 2 | 28 | 16 | 44 |
| 2014 1 | 34 | 11 | 45 |
| 2013 12 | 38 | 16 | 54 |
| 2013 11 | 21 | 18 | 39 |
| 2013 10 | 27 | 18 | 45 |
| 2013 9 | 24 | 22 | 46 |
| 2013 8 | 25 | 14 | 39 |
| 2013 7 | 37 | 21 | 58 |
| 2013 6 | 34 | 25 | 59 |
| 2013 5 | 7 | 4 | 11 |
| 2013 4 | 9 | 6 | 15 |
| 2013 3 | 8 | 7 | 15 |
| 2013 2 | 5 | 5 | 10 |
Mostrar todo
